北東大督

ホクトウダイスケ | Hokuto Daisuke

所属機関・部署：
競争的資金等の研究課題 (4件)：

2019 - 2022 T細胞不活化経路をターゲットとした腫瘍免疫療法と抗腫瘍薬を併用した新規治療の開発
2020 - 2021 消化器癌における静脈血栓塞栓症機序の新概念と次世代型抗血栓療法の開発
2016 - 2019 T細胞不活化経路をターゲットとする大腸癌肝転移の新規免疫療法の開発
2012 - 2014 肝細胞癌のT細胞不活化経路を標的とした癌治療法の臨床導入を目的とした研究

論文 (142件)：

Hiroji Shinkawa, Masaki Kaibori, Daijiro Kabata, Takuya Nakai, Masaki Ueno, Daisuke Hokuto, Hisashi Ikoma, Hiroya Iida, Koji Komeda, Shogo Tanaka, et al. Laparoscopic and open minor liver resection for hepatocellular carcinoma with clinically significant portal hypertension: a multicenter study using inverse probability weighting approach. Surgical endoscopy. 2023
Shunsuke Doi, Satoshi Yasuda, Daisuke Hokuto, Naoki Kamitani, Yasuko Matsuo, Takeshi Sakata, Satoshi Nishiwada, Minako Nagai, Kota Nakamura, Taichi Terai, et al. Impact of the Prolonged Intermittent Pringle Maneuver on Post-Hepatectomy Liver Failure: Comparison of Open and Laparoscopic Approaches. World journal of surgery. 2023
Yuki Imazu, Yasuko Matsuo, Daisuke Hokuto, Satoshi Yasuda, Takahiro Yoshikawa, Naoki Kamitani, Chieko Yoshida, Toshihide Sasaki, Masayuki Sho. Distinct role of tumor-infiltrating lymphocytes between synchronous and metachronous colorectal cancer. Langenbeck's archives of surgery. 2023. 408. 1. 72-72
Daisuke Hokuto, Satoshi Yasuda, Naoki Kamitani, Yasuko Matsuo, Shunsuke Doi, Masayuki Sho. Detailed analysis of recurrent sites after wedge resection for primary hepatocellular carcinoma considering the potential usefulness of anatomic resection: a retrospective cohort study. Langenbeck's archives of surgery. 2023. 408. 1. 29-29
Satoshi Yasuda, Daisuke Hokuto, Naoki Kamitani, Yasuko Matsuo, Shunsuke Doi, Kenji Nakagawa, Satoshi Nishiwada, Minako Nagai, Taichi Terai, Masayuki Sho. Pre- and postoperative C-reactive protein as a risk factor of organ/space surgical site infection after hepatectomy. Langenbeck's archives of surgery. 2023. 408. 1. 13-13

MISC (6件)：

S. Kinoshita, M. Sho, A. Takahiro, T. Nomi, I. Yamato, D. Hokuto, S. Yasuda, Y. Nakajima. The Role of Gemcitabine/S-1 in the Neoadjuvant Setting for Locally Advanced Pancreatic Cancer. PANCREAS. 2012. 41. 7. 1157-1157
M. Sho, T. Tanaka, T. Akahori, S. Kinoshita, T. Yamada, T. Nomi, I. Yamato, D. Hokuto, C. Kawaguchi, S. Yasuda, et al. Novel Multimodal Treatment for Resectable Pancreatic Cancer. PANCREAS. 2012. 41. 7. 1162-1162
童仁, 庄雅之, 野見武男, 赤堀宇広, 山戸一郎, 北東大督, 川口千尋, 安田里司, 木下正一, 金廣裕道, et al. この症例をどうするか「胆」興味ある病態および治療経過を示した高ビリルビン血症の1例. 日本肝胆膵外科学会・学術集会プログラム・抄録集. 2012. 24回. 213-213
M. Sho, T. Tanaka, H. Kanehiro, S. Ko, T. Yamada, T. Nomi, T. Akahori, I. Yamato, D. Jin, D. Hokuto, et al. Novel Postoperative Strategy for Resectable Pancreatic Cancer. PANCREAS. 2009. 38. 8. 1048-1048
M. Sho, I. Yamato, T. Nomi, H. Kanehiro, S. Ko, T. Yamada, T. Akahori, J. Doh, D. Hokuto, Y. Nakajima. Prognostic Significance of CD45Ro+Memory T Cell in Pancreatic Cancer. PANCREAS. 2009. 38. 8. 1048-1048

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

前のページに戻る

北東 大督

北東大督